Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Cash from Financing Activities: 2011-2025

Historic Cash from Financing Activities for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to -$857,000.

  • Mimedx Group's Cash from Financing Activities fell 3274.07% to -$857,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year increase of 87.77%. This contributed to the annual value of -$34.2 million for FY2024, which is 299.05% down from last year.
  • As of Q3 2025, Mimedx Group's Cash from Financing Activities stood at -$857,000, which was up 21.66% from -$1.1 million recorded in Q2 2025.
  • In the past 5 years, Mimedx Group's Cash from Financing Activities ranged from a high of $370,000 in Q3 2023 and a low of -$33.5 million during Q1 2024.
  • Over the past 3 years, Mimedx Group's median Cash from Financing Activities value was -$400,000 (recorded in 2024), while the average stood at -$4.3 million.
  • In the last 5 years, Mimedx Group's Cash from Financing Activities skyrocketed by 200.00% in 2022 and then slumped by 836,575.00% in 2024.
  • Quarterly analysis of 5 years shows Mimedx Group's Cash from Financing Activities stood at $22,000 in 2021, then spiked by 200.00% to $66,000 in 2022, then tumbled by 13,645.45% to -$8.9 million in 2023, then spiked by 95.53% to -$400,000 in 2024, then slumped by 3,274.07% to -$857,000 in 2025.
  • Its Cash from Financing Activities was -$857,000 in Q3 2025, compared to -$1.1 million in Q2 2025 and -$2.9 million in Q1 2025.